Metraipolis › archive › dc_d6ebdbb015ca

The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening — Europe PMC PMID:38792196

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/38792196
DOI: 10.3390/molecules29102333
License (as archived): solo-consultazione
Archived: 2026-10-08T15:29:16.794Z
SHA-256 of the archived text: 16074a16948e472b80e9362ca6c4e6ebd7f259b8d658b8b27af17313e6b001e2
Stable URL of this page: https://metraipolis.com/documento/dc_d6ebdbb015ca

How to cite

The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening — Europe PMC PMID:38792196 — Europe PMC (en), https://europepmc.org/article/MED/38792196 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6ebdbb015ca (Metraipolis archive dc_d6ebdbb015ca, sha256 16074a16948e472b80e9362ca6c4e6ebd7f259b8d658b8b27af17313e6b001e2)

BibTeX

@misc{dcd6ebdbb015ca,
  title = {The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening — Europe PMC PMID:38792196},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38792196},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6ebdbb015ca; sha256 16074a16948e472b80e9362ca6c4e6ebd7f259b8d658b8b27af17313e6b001e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38792196. Agents can read the archived copy with the MCP tool read_document.